Windlas Biotech (India) Insiders
| WINDLAS Stock | 937.75 20.70 2.16% |
Windlas Biotech employs about 1.3 K people. The company is managed by 8 executives with a total tenure of roughly 3141 years, averaging almost 392.0 years of service per executive, having 168.25 employees per reported executive. Breaking down Windlas Biotech's management performance can provide insight into the firm performance.
| Mohammed Aslam President President Marketing |
Windlas |
Windlas Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0596 % which means that it generated a profit of $0.0596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Windlas Biotech's management efficiency ratios could be used to measure how well Windlas Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Total Assets is likely to drop to about 5 B in 2025. Net Tangible Assets is likely to drop to about 2.4 B in 2025Common Stock Shares Outstanding is likely to gain to about 21.8 M in 2025, whereas Net Income Applicable To Common Shares is likely to drop slightly above 319.3 M in 2025.
Windlas Biotech Workforce Comparison
Windlas Biotech Limited is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 42,073. Windlas Biotech holds roughly 1,346 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Windlas Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Windlas Biotech Price Series Summation is a cross summation of Windlas Biotech price series and its benchmark/peer.
Windlas Biotech Notable Stakeholders
A Windlas Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Windlas Biotech often face trade-offs trying to please all of them. Windlas Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Windlas Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mohammed Aslam | President Marketing | Profile | |
| Ashok Windlass | WholeTime Director | Profile | |
| Manoj Windlass | Joint Director | Profile | |
| Hitesh Windlass | MD Director | Profile | |
| Pawan Sharma | Executive Director | Profile | |
| Ananta Panda | Company Officer | Profile | |
| Komal Gupta | Chief Officer | Profile | |
| Om Sule | Site Head | Profile |
About Windlas Biotech Management Performance
The success or failure of an entity such as Windlas Biotech often depends on how effective the management is. Windlas Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Windlas management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Windlas management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Windlas Biotech is entity of India. It is traded as Stock on NSE exchange.
Please note, the imprecision that can be found in Windlas Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Windlas Biotech Limited. Check Windlas Biotech's Beneish M Score to see the likelihood of Windlas Biotech's management manipulating its earnings.
Windlas Biotech Workforce Analysis
Traditionally, organizations such as Windlas Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Windlas Biotech within its industry.Windlas Biotech Manpower Efficiency
Return on Windlas Biotech Manpower
| Revenue Per Employee | 5.6M | |
| Revenue Per Executive | 949.8M | |
| Net Income Per Employee | 453.2K | |
| Net Income Per Executive | 76.2M | |
| Working Capital Per Employee | 2M | |
| Working Capital Per Executive | 344.6M |
Additional Tools for Windlas Stock Analysis
When running Windlas Biotech's price analysis, check to measure Windlas Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windlas Biotech is operating at the current time. Most of Windlas Biotech's value examination focuses on studying past and present price action to predict the probability of Windlas Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windlas Biotech's price. Additionally, you may evaluate how the addition of Windlas Biotech to your portfolios can decrease your overall portfolio volatility.